Antibody Engineering & Therapeutics Asia

Given the rapid growth of the biologics industry in China and increasing interest in innovative biologics beyond biosimilars, IBC is proud to launchAntibody Engineering & Therapeutics Asia in 2015.

This meeting will be co-located with IBC's 7th Annual Bioprocess International China 2015. Together, these two co-located conferences will create the most comprehensive biologics event in Asia covering the entire spectrum of antibody, protein and biotherapeutic development from discovery and preclinical/clinical to process development and manufacturing.

Based on IBC's Antibody Engineering & Therapeutics conference that has been held each December for 25 years in California, this sister conference in Asia will bring together leading scientists and innovators from around the world to discuss novel strategies for antibody, protein and biotherapeutic discovery and development.

If you are working in any of the following areas below, consider submitting a speaker proposal today.

1. Discovery strategies for antibodies, bispecifics, ADCs, fusion proteins

2. Exploiting novel and difficult antibody and protein therapeutic targets

3. Engineering improved antibody developability/ manufacturability

4. Antibody therapeutics for cancer and non-cancer indications

5. Immune checkpoints for target discovery and new agent design

6. Preclinical and clinical data from multiple antibody therapeutic projects